Cystatin C does not detect acute changes in glomerular filtration rate in early diabetic nephropathy

Renal Failure

Volumn 30, Issue 1, 2008, Pages 21-29

  Mueller, Thomas F ^a,b   Raeder, Juliane ^b   Oettl, Karl ^c   Zitta, Sabine ^c   Klausmann, Gert ^d   Estelberger, Willibald ^c   Luyckx, Valerie A ^a   Reibnegger, Gilbert ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d Practice of Diabetology   (Germany)

Author keywords

Creatinine clearance; Cystatin C; Diabetic nephropathy; Glomerular filtration rate; Renal functional reserve

Indexed keywords

CREATINE; CYSTATIN C;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DEMOGRAPHY; DIABETIC NEPHROPATHY; DRUG CLEARANCE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CREATININE; CYSTATINS; DIABETIC NEPHROPATHIES; DIETARY PROTEINS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; OLIGOSACCHARIDES;

EID: 38149018552     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220701741916     Document Type: Article

References (41)

1. Ruggenenti P, Fassi A, Ilieva AP, et al. Preventing microalbuminuria in type 2 diabetes. N Engl J Med. 2004;351(19):1941-1951.
2. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med. 1993;11(329):1456-1462.
3. Brenner BM, Cooper ME, De Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345(12):861-869.
4. Caramori ML, Fioretto P, Mauer M. Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients. An indicator of more advanced glomerular lesions. Diabetes. 2003;52:1036-1040.
5. Fioretto P, Stehouwer CDA, Mauer M, et al. Heterogeneous nature of microalbuminuria in NIDDM: Studies of endothelial function and renal structure. Diabetologia. 1998;41:233-236.
6. Rudberg S, Osterby R. Decreasing glomerular filtration rate - an indicator of more advanced diabetic glomerulopathy in the early course of microalbuminuria in IDDM adolescents. Nephrol Dial Transplant. 1997;12:1149-1154.
7. Rudberg S, Persson B, Dahlquist G. Increased glomerular filtration rate as a predictor of diabetic nephropathy - an eight-year prospective study. Kidney Int. 1992;41(4):822-828.
8. Cooper ME. Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet. 1998;352(9123):213-219.
9. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med. 1982;307(11):652-659.
10. Levey AS. Measurement of renal function in chronic renal disease. Kidney Int. 1990;38(1):167-184.
11. Cameron JS, Greger R. Renal function and testing of function. In: Davison AM, Cameron JS, Grunfeld JP, eds. Oxford Textbook of Clinical Nephrology. New York: Oxford University Press; 1998:39-69.
12. Bosch JP. Renal reserve: A functional view of glomerular filtration rate. Semin Nephrol. 1995;15(5):381-385.
13. Bosch JP, Saccaggi A, Lauer A, et al. Renal functional reserve in humans. Effect of protein intake on glomerular filtration rate. Am J Med. 1983;75(6):943-950.
14. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM. Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol. 1981;241(1):F85-F93.
15. Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders. 5th ed. New York: McGraw-Hill; 2001.
16. Oettl K, Payerl D, Zitta S, et al. Quantitative analysis of sinistrin in serum with high-performance liquid chromatography for renal function testing. Anal Biochem. 2004;331(1):183-188.
17. Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of the renal function - a review. Clin Chem Lab Med. 1999;37(4):389-395.
18. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis. Am J Kidney Dis. 2002;40(2):221-226.
19. Le Bricon T, Thervet E, Benlakehal M, et al. Changes in plasma cystatin C after renal transplantation and acute rejection in adults. Clin Chem. 1999;45(12):2243-2249.
20. Risch L, Blumberg A, Huber A. Rapid and accurate assessment of glomerular filtration rate in patients with renal transplants using serum cystatin C. Nephrol Dial Transplant. 1999;14:1991-1996.
21. Villa P, Jimenez M, Soriano M-C, Manzanares J, Casasnovas P. Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients. Crit Care. 2005;9:R139-R143.
22. Zitta S, Stoschitzky K, Zweiker R, et al. Dynamic renal function testing by compartmental analysis: Assessment of renal functional reserve in essential hypertension. Nephrol Dial Transplant. 2000;15(8):1162-1169.
23. De Santo NG, Cirillo M, Anastasio P, Spitali L, Capasso G. Renal response to an acute oral protein load in healthy humans and in patients with renal disease or liver cirrhosis. Semin Nephrol. 1995;15(5):433-448.
24. Estelberger W, Petek W, Zitta S, et al. Determination of the glomerular filtration rate by identification of sinistrin kinetics. Eur J Clin Chem Clin Biochem. 1995;33(4):201-209.
25. Zitta S, Estelberger W, Holzer H, et al. Pitfalls of single-sample determination of renal clearance. Nephrol Dial Transplant. 2002;17(12):2239-2243.
26. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41.
27. Mueller TF, Reibnegger G. http://www.cliniCALculator.com.
28. Dewitte K, Fierens C, Stockl D, Thienpont LM. Application of the Bland-Altman plot for interpretation of method-comparison studies: A critical investigation of its practice. Clin Chem. 2002;48(5):799-801; 801-802.
29. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307-310.
30. Zatz R. Haemodynamically mediated glomerular injury: The end of a 15-year-old controversy? Curr Opin Nephrol Hypertens. 1996;5(6):468-475.
31. Sackmann H, Tran-Van T, Tack I, et al. Contrasting renal functional reserve in very long-term Type I diabetic patients with and without nephropathy. Diabetologia. 2000; 43(2):227-230.
32. Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 1985;28(5):830-838.
33. Bostom AG, Dworkin LD. Cystatin C measurement: Improved detection of mild decrements in glomerular filtration rate versus creatinine-based estimates? Am J Kidney Dis. 2000;36(1):205-207.
34. Mussap M, Dalla Vestra M, Fioretto P, et al. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int. 2002;61(4):1453-1461.
35. Keevil BG, Kilpatrick ES, Nichols SP, Maylor PW. Biological variation of cystatin C: Implications for the assessment of glomerular filtration rate. Clin Chem. 1998;44(7):1535-1539.
36. Hoek FJ, Kemperman FA, Krediet RT. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant. 2003;18(10):2024- 2031.
37. Newman DJ, Thakkar H, Edwards RG, et al. Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinine. Kidney Int. 1995;47(1):312-318.
38. Rickli H, Benou K, Ammann P, et al. Time course of serial cystatin C levels in comparison with serum creatinine after application of radiocontrast media. Clin Nephrol. 2004;61(2):98-102.
39. Zitta S, Auprich M, Holzer H, Reibnegger G. Cystatin C concentration and glomerular filtration rate. Lancet. 2001;357(9256):635.
40. Sackmann H, Tran-Van T, Tack I, et al. Renal functional reserve in IDDM patients. Diabetologia. 1998;41(1):86-93.
41. Eisenhauer T, Jungmann E, Warneboldt D, et al. Verhalten der renalen Funktionsreserve von Typ I Diabetikern: Einfluss der Konversionshemmung. Klin Wochenschr. 1990;68(2):750-757.